Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Clinical trial NCT07249346 · RECRUITING

Trial details

NCT number

NCT07249346

Sponsor

Hannah Choe, MD

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-06-01

Primary completion

2027-06-01

Enrollment

124

View on ClinicalTrials.gov